Veradermics, Inc (MANE) Corporate Subsidiaries
Veradermics, Inc (MANE) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MANE
CIK: 1827635
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerRichard Tavolieri
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0000019617-26-000348 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001628280-26-060491 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-21 | — | SCHEDULE 13D/A Filing | 0000899140-26-000948 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | FORM 4 | 0000899140-26-000947 | View SEC Doc Filr Page |
| 3 | 2026-08-20 | 2026-08-10 | FORM 3 | 0001628280-26-058305 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0000899140-26-000905 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0000899140-26-000904 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001628280-26-057816 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001628280-26-057813 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001968582-26-000850 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001968582-26-000848 | View SEC Doc Filr Page |
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002672 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-14 | — | SCHEDULE 13D/A Filing | 0001072613-26-000686 | View SEC Doc Filr Page |
| 144/A | 2026-08-14 | — | 144/A Filing | 0001628280-26-057202 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001628280-26-057196 | View SEC Doc Filr Page |
| 424B3 | 2026-08-14 | — | 424B3 | 0001628280-26-057174 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001628280-26-056395 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001628280-26-056391 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001827635-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001827635-26-000028 | View SEC Doc Filr Page |
| S-1 | 2026-08-07 | — | S-1 | 0001628280-26-054921 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002159 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | 8-K | 0001827635-26-000023 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000905148-26-002434 | View SEC Doc Filr Page |
| D | 2026-05-15 | — | D Filing | 0001827635-26-000020 | View SEC Doc Filr Page |